ADMA BIOLOGICS, INC. (ADMA) News Headlines

▮ More

Date

Headline

11/4/2019 7:10:14 AM ADMA Biologics Announces Acceptance To The Plasma Protein Therapeutics Association

10/21/2019 8:17:44 AM ADMA Biologics Announces First Commercial Sales Of ASCENIV

10/17/2019 7:40:42 AM ADMA Biologics Announces Publication Of Article Describing Manufacturing Process Optimization For BIVIGAM And ASCENIV

8/22/2019 7:51:01 AM ADMA Biologics Announces Commercial Relaunch And Its First Commercial Sales Of BIVIGAM

7/8/2019 8:33:54 AM ADMA Biologics Receives FDA Approval For License Transfers For BIVIGAM And Nabi-HB

5/10/2019 7:10:57 AM ADMA Biologics: FDA Approves Prior Approval Supplement For BIVIGAM; Says It Will Commence Commercial Sales Of BIVIGAM

4/4/2019 8:04:37 AM WBB Securities Raises ADMA BIOLOGICS, INC. (ADMA) To Buy From Speculative Buy With $11.50 Price Target

4/2/2019 9:44:25 PM 5 Top Gainers In Healthcare Sector (AVEO, EDAP, ZYNE...)

4/1/2019 10:23:28 PM ADMA Biologics : FDA Okays Asceniv, Intravenous Immune Globulin

3/26/2019 7:16:18 AM Biotech Stocks Facing FDA Decision In April

2/12/2019 9:09:45 PM 5 Top Gainers In Healthcare Sector (CASM, VKTX, ADMA...)

1/7/2019 7:20:55 AM ADMA Biologics Submits Response And Provides Supplemental Information To FDA For BIVIGAM CRL

12/20/2018 12:39:57 AM 7 Stocks That Made Big Moves After-hours (TLRY, SPPI, ADMA, DBVT...)

12/17/2018 7:02:43 AM WBB Securities Starts ADMA BIOLOGICS, INC. (ADMA) At Speculative Buy With $9 Price Target

11/26/2018 12:56:25 AM Biotech Stocks Facing FDA Decision In December

10/17/2018 7:09:20 AM ADMA Biologics Receives PDUFA Date Of April 2, 2019 For RI-002

10/12/2018 2:02:47 AM IMDZ Discontinues SYNOVATE, FDA Delays Decision On ADMA's Bivigam, TRVN Snubbed

10/11/2018 8:49:31 AM ADMA Biologics Provides Regulatory Update For BIVIGAM

10/3/2018 7:12:29 AM ADMA BioCenters Gets FDA Approval For Third Plasma Collection Center

10/1/2018 7:09:15 AM ADMA Biologics Resubmits BLA For RI-002

Adma Biologics, Inc. (ADMA)